Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Acinetobacter, a nosocomial pathogen. Contribution of experimental models].

M L Joly-Guillou1, N Hidri, M Wolff

  • 1Hôpital Louis-Mourier, service de microbiologie, 178, rue des Renouilliers, 92701 Colombes. marie-laure.joly-guillou@lmr.ap-hop-paris.fr

Presse Medicale (Paris, France : 1983)
|May 9, 2002
PubMed
Summary

Acinetobacter infections, often pneumonia in ventilated patients, are increasingly common and difficult to treat due to multi-drug resistant strains. Sulbactam shows promise for treating these challenging Acinetobacter infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Synergistic interactions between doxycycline and terpenic components of essential oils encapsulated within lipid nanocapsules against gram negative bacteria.

International journal of pharmaceutics·2015
Same author

High prevalence of closely-related Acinetobacter baumannii in pets according to a multicentre study in veterinary clinics, Reunion Island.

Veterinary microbiology·2014
Same author

Computing diffuse reflection from particulate planetary surface with a new function.

Applied optics·2010
Same author

Polarization of light reflected from rough planetary surface.

Applied optics·2010
Same author

Surgical technique and validation of outcome assessment in sagittal synostosis.

Central European neurosurgery·2010
Same author

Genesis of a KPC-producing Klebsiella pneumoniae after in vivo transfer from an imported Greek strain.

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin·2010

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Critical Care Medicine

Context:

  • Acinetobacter species are significant nosocomial pathogens, frequently causing outbreaks in intensive care units.
  • Acinetobacter infections, primarily pneumonia in mechanically ventilated patients, pose a growing clinical challenge.

Purpose:

  • To investigate the virulence of clinical Acinetobacter isolates using a mouse model of systemic infection.
  • To evaluate the efficacy of antibiotics, including Sulbactam, in treating Acinetobacter pneumonia in a mouse model.

Summary:

  • Clinical Acinetobacter isolates exhibit multi-drug resistance, complicating treatment options.
  • Animal models, specifically mouse models, are crucial for understanding Acinetobacter physiopathology, pharmacology, and therapeutic efficacy.

Related Experiment Videos

  • Sulbactam, used alone or in combination, has demonstrated success in treating Acinetobacter infections.

    • Impact:

    • This research provides insights into Acinetobacter pathogenesis and informs therapeutic strategies for difficult-to-treat infections.
    • Highlights the importance of developing effective treatments against multi-drug resistant Acinetobacter strains.
    • Emphasizes the utility of animal models in bridging preclinical research and clinical application for Acinetobacter infections.